Drugs / CBD Cannabis
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04800159 Comparator | Feb 2021 → Oct 2025 overdue | HIV infectious disease | University of California, San Diego | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD Cannabis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04800159 ↗ |
| Action | Inhibit | “Cannabis can inhibit the activity of enzymes that metabolize and eliminate ART drugs from the body” NCT04800159 ↗ |
| Route | Other | “Vaporization of cannabis” NCT04800159 ↗ |